Subject: Outcome of the Board meeting held on October 13, 2025 for Capacity Expansion at the Plant located at Dehradun With reference to the captioned subject and our announcement date ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Coral Laboratories approved a capacity expansion at its Dehradun plant on October 13, 2025. The company plans to add 360,000 kgs of ointment manufacturing capacity, effectively doubling the existing capacity of 180,000 kgs (which currently runs at around 80% utilization). The project requires an investment of approximately Rs 30 crores and will be completed within 6 months, funded through bank overdraft and internal accruals. The expansion is aimed at meeting captive demand and supporting sales in both domestic and international markets. The filing also includes a corrigendum correcting minor typographical errors (meeting time and a wording change) from the original announcement.
Positive for shareholders as the doubling of capacity addresses rising demand without requiring equity dilution, though investors should watch for any rise in debt and track execution against the 6-month timeline.